REGENERON PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$927.89
+13.33%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+26.3%
3 months
+22.4%
6 months
+32.6%
1 year
+42.6%
Year to date
+20.7%
52-week range
$599.96 – $927.89
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$95.99B
P/E
19.9
P/B
2.9
P/S
5.7
Revenue
$16.9B
Net income
$4.82B
Diluted EPS
45.3
Gross margin
85.80%
Net margin
28.50%
Return on equity
15.10%
Total debt
$2.71B
Cash
$3.66B
Free cash flow
$3.83B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $5.12B | $1.95B | 88.80% | 38.10% | $1.48B |
| Jun 30, 2026 | $4.29B | $1.3B | 86.60% | 30.20% | $572.8M |
| Mar 31, 2026 | $3.61B | $727.2M | 81.40% | 20.20% | $848.3M |
| Dec 31, 2025 | $3.88B | $844.6M | 84.90% | 21.70% | $922M |
| Sep 30, 2025 | $3.75B | $1.46B | 86.10% | 38.90% | $1.42B |
| Jun 30, 2025 | $3.68B | $1.39B | 85.60% | 37.90% | $925.4M |
| Mar 31, 2025 | $3.03B | $808.7M | 84.70% | 26.70% | $815.8M |
| Dec 31, 2024 | $3.79B | $917.7M | 85.10% | 24.20% | $1.06B |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent REGN news
All market newsNo ticker-linked stories are in the current archive.